Skip to main content

Table 2 Impact of tGSH on the risk of increased neurologic deficits (NIHSS) on admission in stroke patients

From: Plasma glutathione as a risk marker for the severity and functional outcome of acute atherothrombotic and cardioembolic stroke

tGSH, μM

LA

CE

NIHSS < 11

NIHSS > 10

OR (CI 95%)

AOR (CI 95%)

NIHSS < 11

NIHSS > 10

OR (CI 95%)

AOR (CI 95%)

≤ 1.45

6

12

5.14 (1.38–19.1)

4.952 (1.31–18.7)

8

13

1.42 (0.568–2.64)

1.166 (0.281–4.83)

> 1.45

18

7

7

8

  1. AOR adjusted odds ratio, CE cardioembolic stroke, CI 95% 95% coincidence interval, LA large-artery atherosclerosis, NIHSS National Institutes of Health Stroke Scale, OR odds ratio, tGSH total glutathione